Novo Nordisk stock has a neutral daily setup, with modestly positive momentum offset by overhead resistance. The close sits above the 20-session exponential moving average but below the 50- and 200-session averages. The hourly chart offers some support, although its MACD does not confirm a clear bullish bias.
NVO — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
NVO closed Tuesday at $40.19 , down 0.64% from $40.45, below the daily upper Bollinger band at $40.3 and the 50-session EMA at $40.77.
Daily RSI14 is 54.65 (previous 56.74), above the neutral 50; daily MACD histogram is 0.36 with the MACD line at -0.15 above its signal at -0.51.
Hourly RSI14 is 57.32 (previous 53.68), above 50; hourly MACD histogram is -0.08 with the line at 0.27 below its signal at 0.35.
The daily pivot for the next session is $40.26 , with first resistance at $40.56 and first support at $39.89 .
Daily ATR14 reads $0.81 .
On Tuesday, November 3, 2026, NVO opened at $40.34. It traded between a low of $39.96 and a high of $40.63, and closed at $40.19. That was a decline of 0.64% versus the previous close of $40.45 on November 2, 2026.
Novo Nordisk stock: daily resistance limits the bullish case
The daily 20-session EMA stands at $39.35 , beneath the close. However, the 50-session EMA at $40.77 and the 200-session EMA at $45.73 remain above it. This arrangement leaves nearby support beneath price without establishing a bullish trend across the averages.
Meanwhile, daily RSI14 slipped to 54.65 from 56.74, remaining above the neutral 50 threshold. The daily MACD line is -0.15, above its signal at -0.51, with a positive histogram of 0.36. These readings are mixed: relative momentum favors buyers modestly, but the MACD line remains below zero.
The daily Bollinger upper band is $40.3 , just above the close, while the mid-band is $38.95 and the lower band is $37.61. Price therefore sits in the upper half of the envelope, close to an immediate overhead boundary. Daily ATR14 reads $0.81, providing the volatility reference for assessing movements around these levels.
Hourly support meets uneven short-term momentum
On the hourly chart, the session close sits above the 20-hour EMA at $40.11 . It also stands above the 50-hour EMA at $39.64 and the 200-hour EMA at $39.74. However, those averages are not in bullish order because the 50-hour average is below the 200-hour average.
Hourly RSI14 rose to 57.32 from 53.68, placing it above 50. In contrast, the hourly MACD line at 0.27 sits below its signal at 0.35, with a negative histogram of -0.08. The hourly picture therefore supports the daily chart through price position and RSI, but complicates it through MACD. The close also sits below the hourly Bollinger mid-band at $40.27.
For execution context, the close lies below the 15-minute 20-period EMA at $40.27 and 50-period EMA at $40.26. It remains above the 200-period EMA at $39.67. Notably, 15-minute RSI14 rose to 44.87 from 29.5, but remains below 50. Its MACD line of -0.08 is below the signal at -0.06, with a histogram of -0.02. This is not a fully bullish short-term timing backdrop.
News context and next-session scenarios
A report published during Tuesday’s session covered Novo Nordisk’s share repurchase programme , which the company initiated on May 6, 2026. Separately, a report published on Wednesday, November 4, said Novo Nordisk raised its outlook amid continued demand for Wegovy and Ozempic . That later report cannot explain Tuesday’s price move.
Next-session pivot levels
For the next session, the daily pivot sits at $40.26, with first resistance at $40.56 and first support at $39.89. These are forward reference levels derived from the completed daily candle. The hourly pivot for the next session is $40.13, with first resistance at $40.31 and first support at $40.05.
Bullish and bearish scenarios
The bullish scenario requires price to hold above the hourly 20-hour EMA at $40.11 and clear the next-session daily pivot at $40.26. Clearing the daily upper Bollinger band at $40.3 would strengthen that case. Beyond it, the reference points are daily first resistance at $40.56, the session high at $40.63 and the 50-session EMA at $40.77. Acceptance above that average would address the nearest major obstacle on the daily chart.
Conversely, a break below the session low at $39.96 and next-session daily first support at $39.89 would undermine the near-term bullish case. The lower daily references would then be the 20-session EMA at $39.35, the Bollinger mid-band at $38.95 and the lower band at $37.61.
Overall, Novo Nordisk stock stands below the daily upper band at $40.3 and the 50-session EMA at $40.77, with next-session support at $39.89. Daily ATR14 of $0.81 frames the volatility. Whether hourly support can translate into a break through daily resistance remains unresolved.
FAQ
What are the key resistance levels for Novo Nordisk stock?
The daily upper Bollinger band at $40.3, the next-session daily first resistance at $40.56, the session high at $40.63, and the 50-session EMA at $40.77 are the key resistance levels on the daily chart.
What are the key support levels for NVO?
The session low at $39.96, the next-session daily first support at $39.89, and the 20-session EMA at $39.35 are the support references. Further below, the daily Bollinger mid-band at $38.95 and lower band at $37.61 provide additional support.
What does the daily MACD indicate for NVO?
The daily MACD line is -0.15, above its signal at -0.51, with a positive histogram of 0.36. This shows modestly positive momentum, although the MACD line remains below zero.
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What are the key resistance levels for Novo Nordisk stock?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The daily upper Bollinger band at $40.3, the next-session daily first resistance at $40.56, the session high at $40.63, and the 50-session EMA at $40.77 are the key resistance levels on the daily chart.”}},{“@type”:”Question”,”name”:”What are the key support levels for NVO?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The session low at $39.96, the next-session daily first support at $39.89, and the 20-session EMA at $39.35 are the support references. Further below, the daily Bollinger mid-band at $38.95 and lower band at $37.61 provide additional support.”}},{“@type”:”Question”,”name”:”What does the daily MACD indicate for NVO?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The daily MACD line is -0.15, above its signal at -0.51, with a positive histogram of 0.36. This shows modestly positive momentum, although the MACD line remains below zero.”}}]}
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
